Publications by Yu Lueng Shih

Publications by authors named "Yu Lueng Shih"

Claim this Profile

Nitroxoline upregulates low-density lipoprotein receptors expression, enhances lipid metabolism, and reduces hepatic steatosis and atherosclerosis in Apoe mice.

Rou-Ling Cho, Yu-Lueng Shih, Chih-Feng Lien, Yi-Jhen Huang, Pei-Yu Lien

Biochim Biophys Acta Mol Basis Dis· November 2025

Social Media Activity not collected for this article yet.

Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Yu-Lueng Shih

J Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Differential Impact of Interferon-Based and Direct-Acting Antiviral Therapies on Bone Metabolism in Chronic Hepatitis C: Insights from Transcriptomic and Clinical Analyses.

Yi-Lin Chiu, Tsai-Yuan Hsieh, Yu-Juei Hsu, Tien-Yu Huang, Chang-Hung Liao, Yu-Lueng Shih

Calcif Tissue Int· October 2025

Social Media Activity not collected for this article yet.

Chalcone derivative 1m mitigates hepatic fibrosis and inflammation, enhances cholesterol efflux and reduces atherosclerosis.

Chih-Feng Lien, Chin-Sheng Lin, Ching-Yuh Chern, Jia-Yu Chen, Rou-Ling Cho, Yu-Lueng Shih

Int Immunopharmacol· September 2025

Social Media Activity not collected for this article yet.

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection.

Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Yu-Lueng Shih

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection.

Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Yu-Lueng Shih

J Hepatol· April 2025

Social Media Activity not collected for this article yet.

Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease.

Chang-Hung Liao, Peng-Jen Chen, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh

Prev Med Rep· January 2025

Social Media Activity not collected for this article yet.

Rs1347093 regulates microRNA-216/-217 expression and is associated with pancreatic cancer risk.

Hsin-Hung Huang, Tzu-Yue Shiu, De-Chuan Chan, Chao-Feng Chang, Hsuan-Hwai Lin, Yu-Lueng Shih

Pancreatology· December 2024

Social Media Activity not collected for this article yet.

Characteristics and prognosis of small bowel tumors: A retrospective study.

Fang-Chen Liu, Ching-Hsiang Wang, Peng-Jen Chen, Yu-Lueng Shih, Hsuan-Hwai Lin

World J Clin Cases· December 2024

Social Media Activity not collected for this article yet.

Predictors of active and recurrent bleeding in upper gastrointestinal angiodysplasia: Results from 10-year esophagogastroduodenoscopy of a tertiary center in Taiwan.

Meng-Chuan Lu, Tien-Yu Huang, Peng-Jen Chen, Hsuan-Wei Chen, Chih-Wei Yang, Yu-Lueng Shih

Medicine (Baltimore)· December 2024

Social Media Activity not collected for this article yet.

Promoter hypermethylation-mediated downregulation of PAX6 promotes tumor growth and metastasis during the progression of liver cancer.

Ching-Hua Yeh, Rou-Yu Chen, Ti-Hui Wu, Shan-Yueh Chang, Tsai-Yuan Hsieh, Yu-Lueng Shih

Clin Epigenetics· November 2024

Social Media Activity not collected for this article yet.

Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.

Hsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, Wen-Hui Fang, Chang-Hsien Liu

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.

Chen-Hua Liu, Yu-Ping Chang, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Yu-Lueng Shih

J Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.

Chen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Yu-Lueng Shih

J Med Virol· May 2024

Social Media Activity not collected for this article yet.

Clinical implications of hepatitis B virus core antigen-mediated immunopathologic T cell responses in chronic hepatitis B.

Li-Tzu Wang, Yu-Hong Chen, Yang Cheng, Hsiu-Lung Fan, Teng-Wei Chen, Yu-Lueng Shih

J Med Virol· March 2024

Social Media Activity not collected for this article yet.

Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib.

Meng-Chuan Lu, Wen-Yen Huang, Hsiu-Lung Fan, Teng-Wei Chen, Wei-Chou Chang, Yu-Lueng Shih

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan.

Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, Chi-Yi Chen, Ching-Chu Lo, Yu-Lueng Shih

Hepatol Int· April 2023

Social Media Activity not collected for this article yet.

SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer.

Shan-Yueh Chang, Ti-Hui Wu, Yu-Lueng Shih, Ying-Chieh Chen, Her-Young Su

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, Szu-Min Hsieh, Sheng-Shun Yang, Yu-Lueng Shih

Open Forum Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Evolution of congenital haemophilia care in Taiwan.

Yeu-Chin Chen, Chia-Yau Chang, Shin-Nan Cheng, Ru-Yu Pan, Yu-Lueng Shih

J Formos Med Assoc· March 2022

Social Media Activity not collected for this article yet.

Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment.

Chen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, Sheng-Shun Yang, Yu-Lueng Shih

Aliment Pharmacol Ther· February 2022

Social Media Activity not collected for this article yet.

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.

Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, Pei-Chien Tsai, Tsai-Yuan Hsieh, Yu-Lueng Shih

World J Gastroenterol· January 2022

Social Media Activity not collected for this article yet.

SPAK Deficiency Attenuates Chemotherapy-Induced Intestinal Mucositis.

Tien-Yu Huang, Sung-Sen Yang, Ching-Len Liao, Ming-Hong Lin, Hsuan-Hwai Lin, Yu-Lueng Shih

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis.

Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Yu-Lueng Shih

Clin Mol Hepatol· October 2021

Social Media Activity not collected for this article yet.

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads.

Wei-Chou Chang, Hsian-He Hsu, Sung-Hua Chiu, Wen-Yen Huang, Cheng-Hsiang Lo, Yu-Lueng Shih

J Hepatocell Carcinoma· August 2021

Social Media Activity not collected for this article yet.

Socials: